Mario Saltarelli is the CEO and CMO of GABA Therapeutics, with over 20 years of experience in CNS drug development for neurological and psychiatric disorders. He earned his MD and PhD from The Johns Hopkins University School of Medicine, where he also serves as an adjunct Assistant Professor.
He was recognized with the Bronze Tablet for high scholastic achievement during his undergraduate studies at the University of Illinois Urbana-Champaign.
Unique fact: He holds a patent for a method of using NMDA NR2B antagonists to treat neurodegeneration, hearing loss, and vision loss.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.